𝔖 Bobbio Scriptorium

✦ LIBER ✦

Rapid in vivo development of influenza a (H3N2) virus resistance to amantadine and rimantadine: R.W. Sidwell, K.W. Bailey, M.H. Wong, A.G. Morrison, and J.H. Huffman. Inst. for Antiviral Research, Utah State University, Logan, UT 84322-5600 USA

Book ID: 113259401
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 76 KB
Volume: 26
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(95)94931-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vivo influenza virus-inhibitory activ

In vivo influenza virus-inhibitory activity of an orally administered neuraminidase inhibitor: R.W. Sidwell1, J.H. Huffman1, K.W. Bailey1, M.H. Wong1 and C.U. Kim2. 1Inst. for Antiviral Research, Utah State Univ., Logan, UT and 2Gilead Sciences, Inc., Foster City, CA, USA.

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 109 KB

In vitro and in vivo influenza-inhibitor

In vitro and in vivo influenza-inhibitory effects of a series of polyoxometalates: R. W. Sidwell1, J. H. Huffman1, K. W. Bailey1, A. Gessaman1, M. J. Otto2, C. Hill3 and R. F. Schinazi3. Inst. for Antiviral Res., Utah State Univ., Logan, UT 84322-56001; Avid Therapeutics, Inc., Philadelphia, PA 191042, and VA Medical Ctr.Emory Univ., Decatur, GA 300333, USA

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 68 KB

62 In vivo influenza-inhibitory effects

62 In vivo influenza-inhibitory effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 : R.W. Sidwell1, D. F. Smee1, K. W. Bailey1, J. H. Huffman1, D. L. Barnard1, M.-H. Wong1, K. Bush2 and Y. S. Babu3. 1Inst. for Antiviral Res., Utah State Univ., Logan, UT, USA. 2The R. W. Johnson Pharm. Res. Inst., Raritan, NJ, USA. 3BioCryst Pharmaceuticals Inc., Birmingham, AL, USA

📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 130 KB

61 A new class of cyclopentane derivativ

61 A new class of cyclopentane derivatives with potent inhibitory activity against influenza A and B viruses in cell culture : D.F. Smee1, A.C. Morrison1, J.H. Huffman1, D.L. Barnard1, P.C. Wagaman2, K. Bush3, and R.W. Sidwell1. 1Institute for Antiviral Research, Utah State University, Logan, UT, USA. R.W. Johnson Pharmaceutical Research Institute, La Jolla, CA2 and Raritan, NJ3, USA

📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 127 KB